The scientific world is constantly striving to find ways to make the treatment of cancer and other serious diseases more effective. One of the main problems of modern medicine is that active substances have difficulty crossing the body’s natural barriers. The result is low absorption, the need for higher dosages, and often significant side effects.
A study confirming the importance of nanotechnology
A recently published study by Chinese scientific institutions, entitled “Unique therapeutic potentialities of exosomes based nanodrug carriers to target tumor microenvironment in cancer therapy” (OpenNano, 2022), brings clear conclusions: the future of pharmacology lies in nanotechnology.
The authors show that nanoparticles can significantly improve drug absorption, allow administration in lower doses, reduce interactions with other medications, and at the same time limit side effects. In their work, the researchers focused on particles sized 50–100 nanometers and described their ability to directly target tumor cells within the complex tumor microenvironment.
Read the study here.
Liposomes as the ideal carrier
A key role is played by lipid nanoparticles – structures similar to cell membranes. Among them, liposomes stand out as the most promising carriers of active substances. Their advantages are clear:
- they protect the drug from degradation,
- ensure better absorption and bioavailability,
- enable targeted action at the site of disease,
- reduce toxicity and side effects compared to conventional therapy.
Compared to other nanocarriers – such as metallic or polymeric particles – liposomes have the advantage of being natural to the body, easily biodegradable, and non-toxic.
What science is discovering today, we have been doing for 8 years
And this is exactly where global science and our everyday practice meet. What Chinese scientists describe in their study as the future is precisely what we at Unique Therapeutics have been doing for more than eight years.
Our liposomal nanoformulations are designed to be even more effective. While the mentioned study worked with nanoparticles sized 50–100 nm, we deliberately produce particles with a diameter of around 20 nm – up to five times smaller. As a result, our therapeutics achieve even faster absorption and higher efficacy at lower dosages.
The future that begins today
The conclusions of the study are clear: liposomal nanoparticles represent a path to improving drug efficacy, reducing the burden on the body, and moving closer to truly personalized medicine. At Unique Therapeutics, we are proud to have been working with this technology for years, helping to push the boundaries of what is possible in treatment.
We thank the world’s scientific institutions for confirming our view of the future of medicine. A future that is not far away – for us, it began more than eight years ago.